164126011 - Project: tender_21202 - ACAN - Fully Automated NAAT Assay System for Qualitative Detection and Differentiation of HIV-1 and HIV-2 in Human Serum, Plasma and Dried Blood Spots (Канада - Тендер #67448725) | ||
| ||
| Для перевода текста тендера на нужный язык воспользуйтесь приложением: | ||
Страна: Канада (другие тендеры и закупки Канада) Организатор тендера: www.merx.com Номер конкурса: 67448725 Дата публикации: 03-10-2025 Источник тендера: www.merx.com |
||
Advanced Contract Award Notice for a fully automated NAAT assay system for HIV-1 and HIV-2 detection and differentiation, with intent to award a seven-year contract to Roche Diagnostics as the sole provider.
00004741153
Issuing OrganizationOntario Shared Services
Solicitation TypeACAN - Advance Contract Award Notice (Formal)
Solicitation Number164126011
TitleProject: tender_21202 - ACAN - Fully Automated NAAT Assay System for Qualitative Detection and Differentiation of HIV-1 and HIV-2 in Human Serum, Plasma and Dried Blood Spots
Source IDSCRIBE
Ontario
Purchase TypeNot Stated
2025/10/02 12:41:00 PM EDT
Closing Date2025/10/16 04:00:00 PM EDT
Julie Capotorto
julie.capotorto@oahpp.ca
Public Health Ontario (PHO) believes that the following procurement qualifies as a sole source or single source procurement. The purpose of this Advanced Contract Award Notice (ACAN) is to
determine if there are other suppliers capable of meeting the requirements of the procurement for the following services for PHO.
Vendor – Roche Diagnostics
Services – Outlined in the ACAN
Purpose – Fully Automated NAAT Assay System for Qualitative Detection and Differentiation of HIV-1 and HIV-2 in Human Serum, Plasma and Dried Blood Spots
Public Health Ontario (PHO) serves as the reference laboratory for HIV testing in the province of Ontario. PHO follows the HIV diagnostic algorithm developed by the Centers for Disease Control
and Prevention (CDC). This process begins with an enzyme immunoassay (EIA) for initial screening. If the EIA result is positive, a confirmatory antibody test is conducted. In cases where the
confirmatory antibody test yields negative or inconclusive results, nucleic acid amplification testing (NAAT), also known as polymerase chain reaction (PCR), is performed.
PHO believes that Roche Diagnostics is the sole provider capable of providing all required goods in the Canadian Market that is Health Canada approved.
PHO intends to award a seven (7) year contract to Roche Diagnostics for the goods described in the ACAN attachment.